In our study, pretreatment with DaMe led to the downregulation of the PINK1 gene expression in an in vitro model of PD in which ROS generation and the relative upregulation of the PINK1 gene balanced the oxidative reactions and mitochondrial instability within the cell. The gene discussed is PINK1; the disease is Parkinson disease.